TipRanks on MSN3h
Blueprint Medicines initiated with an Overweight at JPMorgan
JPMorgan initiated coverage of Blueprint Medicines (BPMC) with an Overweight rating and $126 price target Blueprint is a ...
Money Talks News on MSN27m
JP Morgan CEO Jamie Dimon: ‘Conditions Are Treacherous and Getting Worse.’ 4 Things to Do Now.
In a recent interview, J.P. Morgan CEO Jamie Dimon expressed growing concerns about what’s happening in the world today, ...